Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02614040 · ClinicalTrials.gov registry record · NA

Saline Against Lactated Ringers or Plasmalyte in the Emergency Department

A NA study of Critical Illness and Acute Kidney Injury, sponsored by Vanderbilt University.

Completed
Registry status
NA
Development phase
14,000
Enrollment target
1
Study location

NCT02614040 is a NA study of Critical Illness and Acute Kidney Injury that has completed, run by Vanderbilt University. The registered enrollment target is 14,000 participants, above the 2,985-participant average among 91 other Critical Illness trials with a reported enrollment target (369% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02614040, a NA study of Critical Illness and Acute Kidney Injury, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
NA
Development phase
14,000 participants
Enrollment target
1
Study location

Study Summary

This study will be a cluster-randomized, single-center trial comparing 0.9% saline (normal saline) vs physiologically-balanced crystalloid fluids (Lactated Ringers or Plasmalyte A) for intravenous fluid administration in the emergency department.

Interventions

  • OTHER 0.9% Saline
  • OTHER Physiologically-balanced isotonic crystalloid

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center Adult Emergency Department - Nashville

Trial Details

FieldValue
Enrollment Target 14,000 participants
Start Date 2016-01-01
Est. Completion 2017-06-30
Phase NA

Sponsor

Vanderbilt University

430 total trials

What the Registry Record Tells You About NCT02614040

The ClinicalTrials.gov registry entry for NCT02614040 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,985-participant average among 91 other Critical Illness trials with a reported enrollment target (369% higher). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Critical Illness appearing as the primary indexed condition, and to 2 interventions - of which 0.9% Saline is the first listed.

NCT02614040 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT02614040 about?

NCT02614040 is a clinical study titled "Saline Against Lactated Ringers or Plasmalyte in the Emergency Department". This study will be a cluster-randomized, single-center trial comparing 0.9% saline (normal saline) vs physiologically-balanced crystalloid fluids (Lactated Ringers or Plasmalyte A) for intravenous fluid administration in the emergency department.

What is the current status of trial NCT02614040?

This trial is currently completed. It is a NA study. The enrollment target is 14,000 participants. The study started on 2016-01-01. Estimated completion is 2017-06-30.

What conditions does trial NCT02614040 study?

This clinical trial studies the following conditions: Critical Illness, Acute Kidney Injury.

What interventions are being tested in trial NCT02614040?

The interventions under investigation include: 0.9% Saline (OTHER), Physiologically-balanced isotonic crystalloid (OTHER).

Who is sponsoring clinical trial NCT02614040?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02614040 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.